RGEN - Bathi sing dikarepake Repligen Corp

Logo grafis Repligen Corporation (RGEN)

Global logistics risks and export restrictions are putting pressure on Repligen Corporation (RGEN) technology deliveries. The organization's future profit trend visualizes the revenue consensus, where 0.17 expresses today's metric value. An active M&A strategy offsets the industry downturn, yet stringent bioprocessing regulatory standards create high barriers, making it difficult for clients to switch suppliers due to the high cost of process recertification.

RGEN: Prakiraan bathi perusahaan Repligen Inc. 04.07.2022 - 16.11.2026

Rincian metrik lan analitis perusahaan Repligen Inc. (RGEN)

Analisis umum perusahaan:Repligen
Produk dadi Repligen Corp.

Repligen Corporation (RGEN) strategic alliances in bioprocessing and the acquisition of filtration startups are building long-term revenue scaling potential. Analyzing the company's target profit levels, investors assess the consensus net income forecast, which offsets reporting volatility and allows for the determination of business maturity through the stability of financial expectations, revealing hidden risks of growth deceleration.

Analisis pesaing Repligen Corporation

Bathi sing dikarepake Tempus AI|Proyeksi bathi mangsa ngarep Qiagen|Proyeksi bathi mangsa ngarep IONS|Prakiraan bathi perusahaan Avidity Biosciences|Bathi sing dikarepake CRISPR Therapeutics Corp CRSP|WGS: Prakiraan bathi resik|ultragenyx.com - Proyeksi bathi mangsa ngarep|Beam Therapeutics - Bathi resik mangsa ngarep|SRPT: Proyeksi bathi mangsa ngarep|TWST (Twist Bio) - Bathi sing dikarepake|TXG (10xgenomics.com) - Proyeksi bathi mangsa ngarep|Proyeksi bathi mangsa ngarep Intellia Therapeutics, Inc.|Proyeksi bathi mangsa ngarep STOK|Prakiraan bathi perusahaan BioLife Solutions Inc|Bathi sing dikarepake Wave Pharma WVE|Proyeksi bathi mangsa ngarep Maze Therapeutics Corp MAZE|SION - Bathi sing dikarepake|Prime Medicine, Inc. (PRME) - Bathi mangsa ngarep|TSHA (Taysha Gene Therapies, Inc.) - Bathi mangsa ngarep|QURE - Prakiraan bathi perusahaan|MGTX (MeiraGTx Holdings plc) - Proyeksi bathi mangsa ngarep|Bathi mangsa ngarep REGENXBIO Inc. (RGNX)|Bathi sing dikarepake Solid Biosciences (SLDB)|ocugen.com (OCGN) - Proyeksi bathi resik|Proyeksi bathi mangsa ngarep PACB (PacBio Corp)|Penghasilan resik sing dikarepake BNTC|DSGN: Bathi mangsa ngarep|RCKT - Proyeksi bathi mangsa ngarep|Penghasilan resik sing dikarepake 4D Molecular Corp FDMT|Bathi mangsa ngarep Lexeo|Bathi sing dikarepake Korro Bio Inc.|Prakiraan bathi resik EDIT (Editas Medicine)|Bathi sing dikarepake Silence Therapeutics Corp (SLN)|PRQR (ProQR) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep CDXS (Codexis, Inc.)|Prakiraan bathi perusahaan sangamo.com (SGMO)|nautilus.bio - Proyeksi bathi mangsa ngarep|Metagenomi (MGX) - Bathi mangsa ngarep|DTIL: Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Generation Bio Co (GBIO)|BOLD (Boundless Bio) - Proyeksi bathi mangsa ngarep|Bathi mangsa ngarep Exicure (XCUR)|Bathi sing dikarepake Celsion Corporation (IMNN)|PHIO - Bathi resik sing dikarepake|Mustang Bio Inc - Bathi mangsa ngarep|Proyeksi bathi mangsa ngarep transcodetherapeutics.com RNAZ|Bionano Genomics Inc. - Proyeksi bathi mangsa ngarep|APDN (Applied DNA Sciences) - Prakiraan bathi resik|BLUE (bluebirdbio.com) - Bathi mangsa ngarep|Prakiraan bathi resik IPA|OMGA (omegatherapeutics.com) - Proyeksi bathi mangsa ngarep|Singular Genomics Systems Inc (OMIC) - Prakiraan bathi perusahaan|Proyeksi bathi mangsa ngarep RGLS|Prakiraan bathi perusahaan Syros Pharmaceuticals, Inc.|Bathi sing dikarepake Telesis Bio Inc. TBIO|Bathi resik mangsa ngarep TCON (TRACON Pharmaceuticals Inc.)|Unity Bio - Proyeksi bathi mangsa ngarep